RDNT at a glance
RadNet, Inc. (RDNT, SEC CIK 790526) filed its latest 10-K annual report on March 2, 2026, a 10-Q quarterly report on August 10, 2026, an 8-K current report on August 14, 2026 and Form 4 insider filings as recently as June 22, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), RadNet, Inc. (RDNT) reported revenue of $2.0 billion (up 11.5% from FY2024) and a net loss of $18.7 million. Diluted EPS was -$0.25.
- As of June 30, 2026, 32 institutional investment managers tracked by SignalX reported holding RadNet, Inc. (RDNT) shares worth $2.2 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by SWARTZ DAVID L on June 18, 2026 of 2,699 shares at $53.89 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $2.0B
- +11.5% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 32 funds
- $2.2B · −1 vs prior quarter
- Latest 8-K
- Aug 14, 2026
- Item 8.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model: Diagnostic imaging services revenue from patients and third-party payors under fee-for-service and capitation contracts
- Emphasis on capitation arrangements earning per-enrollee monthly revenue for making imaging services available to health plan members
- Business combination accounting impacting goodwill and asset valuations with possible adjustments up to one year post-acquisition
- Accounts receivable primarily from insurance and government programs, with continuous monitoring and allowances for credit losses
- No introduction of new products or segments but focus on contractual revenue estimation and collection practices
Risk Factors
- CMS 2026 Physician Fee Schedule final rule may reduce Medicare reimbursement rates and imaging volumes starting CY 2026
- Significant exposure to California natural disasters: headquarters and 100+ centers vulnerable to wildfires, blackouts, earthquakes
- Dependence on contracted radiology groups for managed care contracts; termination risks revenue loss and competitive position
- Competition from private equity-backed chains and hospitals, risking market share due to their greater financial resources and newer equipment
- Majority of indebtedness at variable rates; rising interest rates increase borrowing costs and may reduce profitability
Management Discussion & Analysis
- Revenue $2.04B in 2025, up 11.5% YoY from $1.83B in 2024; Imaging Center revenue $1.99B up 10.9% YoY
- Operating margin 3.0% in 2025 vs 5.7% in 2024; net income margin 0.8% in 2025 vs 2.0% in 2024
- Best performing segment: Imaging Center $1.99B revenue (+$196M, +10.9% YoY); worst: Digital Health $92.7M revenue (+$27M, +41.0% YoY) but smaller scale
- Operating expenses rose 13.2% to $1.89B in 2025 driven by volume growth, wages, and medical supplies; stock comp increased 66.3% to $44.7M
- Capital allocation: acquisitions totaled $229.8M in 2025 (iCAD $110.7M, CIMAR $37M, See-Mode $28.9M), no data on buybacks/dividends disclosed
- Management highlights expansion in Digital Health via AI acquisitions; identifies risks from wage inflation, supply costs, and weather impacting Q1 volumes
AI summary of the RDNT 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Risk Factors
- No material changes identified; quarterly filing refers readers to Annual Report risk factors
- Additional unknown or currently immaterial risks could materially adversely affect operations or financial condition
- Incremental Amendment No. 3 to credit agreement dated June 10, 2026 indicates updated debt financing terms
- No directors or executive officers adopted or terminated Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during quarter
AI summary of the RDNT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- Resale registration for up to 34,069 RadNet shares issued to See-Mode sellers
- Shares represent milestone-based consideration under the June 2, 2025 See-Mode acquisition agreement
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026, released August 9, 2026
- Detailed financial results furnished in Exhibit 99.1 press release
Item EX-99.1: Item EX-99.1
- Q2 revenue reached a record $622.7M, up 25.0%, with Adjusted EBITDA up 22.7% to $99.7M
- Advanced imaging mix rose to 29.9% from 27.5%, supporting Imaging Center EBITDA margin expansion to 16.1%
Item 2.03: Creation of a Direct Financial Obligation
- Item 2.03 indicates a newly created direct financial obligation or off-balance-sheet obligation
Item 1.01: Entry into a Material Definitive Agreement
- $250.0M incremental term loan expands funding for acquisitions, organic growth, health system partnerships, and corporate purposes
- Term Loan maturity remains April 18, 2031, alongside $958.7M existing term loan balance
Item 7.01: Regulation FD Disclosure
- Regulation FD disclosure furnished, not filed under Exchange Act Section 18
- Information excluded from Securities Act registration-statement incorporation by reference
AI summaries of RDNT 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for RDNT
Don't miss the next RDNT filing
- Alerts as it files. A push when RDNT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut RDNT, by share count.
- Ask anything. An AI agent that reads every RDNT filing and answers with sources.
RDNT alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| SWARTZ DAVID L | Sell | Jun 18, 2026 | 2,699 | $53.89 |
| Berger Howard G | G | Jun 16, 2026 | 90 | - |
| Wesdorp Cornelis | Sell | Jun 16, 2026 | 4,750 | $58.11 |
| Forthuber Stephen M | Sell | Jun 15, 2026 | 19,853 | $58.61 |
| Forthuber Stephen M | Sell | Jun 15, 2026 | 24,214 | $57.79 |
| SWARTZ DAVID L | A | Jun 2, 2026 | 2,946 | - |
| SPURLOCK GREGORY E. | A | Jun 2, 2026 | 2,946 | - |
| Levitt Lawrence L | A | Jun 2, 2026 | 2,946 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $1.6B | $1.8B | $2.0B |
| Operating Income | $98.7M | $104.6M | $62.0M |
| Net Income | $3.0M | $2.8M | -$18.7M |
| Op. Margin | 6.1% | 5.7% | 3.0% |
| Net Margin | 0.2% | 0.2% | -0.9% |
| Balance Sheet | |||
| Total Assets | $2.7B | $3.3B | $3.8B |
| Equity | $630.7M | $902.3M | $1.1B |
| ROE | 0.5% | 0.3% | -1.7% |
| Per Share | |||
| EPS | $0.05 | $0.04 | $-0.25 |
| Cash Flow | |||
| Operating CF | - | $233.0M | $298.8M |
Source: XBRL data in RadNet, Inc. (RDNT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate RDNT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 32 | $2.21B |
| Q1 2026 | 33 | $1.94B |
| Q4 2025 | 30 | $2.46B |
| Q3 2025 | 30 | $2.44B |
| Q2 2025 | 29 | $1.72B |
| Q1 2025 | 25 | $1.04B |
| Q4 2024 | 22 | $1.29B |
| Q3 2024 | 19 | $746.3M |
- BlackRock+922.1K (+9%)
- Millennium Management+419.0K (+900%)
- T. Rowe Price Group+346.3K (+8%)
- State Street Corp+190.9K (+7%)
- Vanguard Portfolio Management LLC+167.8K (+4%)
- Franklin Resources−453.0K (-99%)
- Soros Fund Management−321.9K (-73%)
- FMR LLC (Fidelity)−210.5K (-95%)
- Bank of America Corp−168.9K (-29%)
- Ameriprise Financial−153.5K (-17%)
- Regions Financial Corporation+9.4K
- M&T Bank+3.8K
- D.E. Shaw & Co−50.5K
- Citadel Advisors LLC−23.7K
- Two Sigma Investments−4.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 220 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
RDNT filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Aug 14, 2026 | - | Analysis | - |
| 8-K | Aug 10, 2026 | - | Analysis | - |
| 10-Q | Aug 10, 2026 | Jun 30, 2026 | Analysis | |
| 4 | Jun 22, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 16, 2026 | - | - | - |
| 8-K | Jun 10, 2026 | - | Analysis | |
| 8-K | Jun 4, 2026 | - | Analysis | |
| 4 | Jun 3, 2026 | - | - | |
| 4 | Jun 3, 2026 | - | - | |
| 4 | Jun 3, 2026 | - | - | |
| 4 | Jun 3, 2026 | - | - | |
| 8-K | Jun 3, 2026 | - | Analysis | |
| SC 13G | May 15, 2026 | - | - | |
| 8-K | May 11, 2026 | - | Analysis | |
| 10-Q | May 11, 2026 | Mar 31, 2026 | Analysis | |
| 4 | May 6, 2026 | - | - | |
| SC 13G | Apr 29, 2026 | - | - | |
| 4 | Mar 23, 2026 | - | - | - |
| 4 | Mar 18, 2026 | - | - | - |
| 4 | Mar 12, 2026 | - | - | - |
| 4 | Mar 5, 2026 | - | - | - |
| 4 | Mar 5, 2026 | - | - | - |
| 4 | Mar 5, 2026 | - | - | - |
Related Health Care companies
- CDNA · CareDx, Inc.Services-Medical Laboratories
- CSTL · CASTLE BIOSCIENCES INCServices-Medical Laboratories
- CELC · Celcuity Inc.Services-Medical Laboratories
- FTRE · Fortrea Holdings Inc.Services-Medical Laboratories
- FLGT · Fulgent Genetics, Inc.Services-Medical Laboratories
- GRAL · GRAIL, Inc.Services-Medical Laboratories
- GH · Guardant Health, Inc.Services-Medical Laboratories
- LH · LabcorpServices-Medical Laboratories
RDNT SEC filings: frequently asked questions
Which institutions hold RDNT stock?
As of June 30, 2026, the largest RadNet, Inc. (RDNT) holders among the 13F filers tracked by SignalX were BlackRock ($675.8 million), T. Rowe Price Group ($277.6 million), Vanguard Portfolio Management LLC ($250.8 million), Vanguard Capital Management LLC ($196.9 million), State Street Corp ($175.2 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was RDNT's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), RadNet, Inc. (RDNT) reported revenue of $2.0 billion (up 11.5% from FY2024) and a net loss of $18.7 million. Diluted EPS was -$0.25. The figures come from the XBRL data in the 10-K.
What are the main risks in RDNT's latest 10-K?
In the 10-K filed March 2, 2026, RadNet, Inc. (RDNT) flagged: CMS 2026 Physician Fee Schedule final rule may reduce Medicare reimbursement rates and imaging volumes starting CY 2026. Significant exposure to California natural disasters: headquarters and 100+ centers vulnerable to wildfires, blackouts, earthquakes. (AI summary of the Risk Factors section.)
What did RDNT report in its latest 8-K?
RadNet, Inc. (RDNT) filed an 8-K on August 14, 2026 reporting Item 8.01 (Other Events). Resale registration for up to 34,069 RadNet shares issued to See-Mode sellers.
What are the latest RDNT SEC filings?
RadNet, Inc. (RDNT) filed its latest 10-K annual report on March 2, 2026, a 10-Q quarterly report on August 10, 2026, an 8-K current report on August 14, 2026 and a Form 4 insider filing on June 22, 2026.
What is RDNT's SEC CIK number?
RadNet, Inc. (RDNT)'s SEC Central Index Key (CIK) is 790526. EDGAR lists every RDNT filing under that number.
Ask anything about RDNT
The research agent reads RDNT's filings, financials, insider trades and 13F holders, then answers with sources.